Roswell Park-Led Analysis Shows Survival Benefit of Lenalidomide...

New research analysis published in JCO definitively shows an overall survival benefit from ongoing treatment with lenalidomide for patients with multiple myeloma who have already received bone marrow...(PRWeb August 15, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14605233.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news